Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127373 · ClinicalTrials.gov registry record · NA
Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT01127373: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01127373 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01127373, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
This study is being performed to understand the safety of a new radiation treatment called "Multi-Beam Intensity Modulated Radiation Therapy" ( IMRT). Currently, the standard way of giving radiation is with "simplified" IMRT, which uses only 2 beams of radiation. "Multi-beam" IMRT works by using 6-12 small radiation beams to give a more "tailored" or "customized" radiation dose to the breast, chest wall, and the lymph nodes. At the same time, multi-beam IMRT may allow the dose to the heart, lungs, and nearby tissue to be lowered, especially when the internal mammary lymph nodes need to be targeted by radiation.
Interventions
- RADIATION Multi-Beam Intensity-Modulated Radiation Therapy
- BEHAVIORAL BreastQ questionnaire-
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2010-05-11 |
| Est. Completion | 2019-10-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01127373
The ClinicalTrials.gov registry entry for NCT01127373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Multi-Beam Intensity-Modulated Radiation Therapy is the first listed.
NCT01127373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01127373 about?
NCT01127373 is a clinical study titled "Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer". This study is being performed to understand the safety of a new radiation treatment called "Multi-Beam Intensity Modulated Radiation Therapy" ( IMRT). Currently, the standard way of giving radiation is with "simplified" IMRT, which uses only 2 beams of radiation. "Multi-beam" IMRT works by using 6-1...
What is the current status of trial NCT01127373?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2010-05-11. Estimated completion is 2019-10-02.
What interventions are being tested in trial NCT01127373?
The interventions under investigation include: Multi-Beam Intensity-Modulated Radiation Therapy (RADIATION), BreastQ questionnaire- (BEHAVIORAL).
Who is sponsoring clinical trial NCT01127373?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.